this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization
Bio Photo

Home
About BIO
Conferences & Events
Past BIO Events
Industry Calendar
State/Int'l Calendar
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
BIO Blogs & Podcasts
National Issues
Health
Food & Agriculture
Industrial & Environmental
• Bioethics
Intellectual Property
Regulatory
Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Business & Finance


Sunday, September 07, 2008

Bioethics Committee

Click here for a printer-friendly page Printer Friendly

BIO Staff Contact: Sara Radcliffe, Vice President, Science & Regulatory Affairs

Committee Chairs: Joshua Boger, Co-chair, Chairman, President & CEO Vertex Pharmaceuticals, Inc.

Mission: BIO is committed to the socially responsible use of biotechnology to save or improve lives, improve the quality and abundance of food, and protect our environment. BIO's board of directors has adopted a Statement of Ethical Principles, and we continue to refine a comprehensive vision of ways to ensure biotechnology is used for the betterment of humankind and not abused.

Responsibilities:

  • The Bioethics Committee is responsible for actively encouraging discussion of ethical and social implications of scientific developments in biotechnology. Biotechnology can greatly improve the quality of life, but we recognize that this new technology should be approached with an appropriate mixture of enthusiasm, caution and humility.
  • The committee works with state, federal and international legislative and regulatory bodies to shape policies that foster safe, effective and beneficial products.
  • The committee works with BIO staff to brief members of Congress and officials of governmental agencies such as the National Institutes of Health, the Food and Drug Administration, other branches of the Department of Health and Human Services and the President's Council on Bioethics on bioethical matters.
  • Committee members may be asked to develop bioethics-related position papers, white papers and educational materials.
  • Committee members may be asked to formulate comments and testimony on various bioethics-related guidelines and regulations.

Policy Approval Process: Substantive matters designed to become the official position of BIO are sent as recommendations of the Bioethics Committee to the board of directors for consideration.

Issues: Since its implementation, the Bioethics Committee has considered such issues as stem cell research, cloning, global health, use of genetic information, medical records confidentiality and protection of human subjects.

Eligibility for Participation: To become a member of the Bioethics Committee, one must be a member of BIO’s Board of Directors.

Contact Information: For more information on the Committee, and Bioethics at BIO, email bioethics@bio.org.

Addresses and Phone Numbers: 1201 Maryland Avenue, SW, Suite 900, Washington, DC 20024-2149; (202) 962-9200; fax: (202) 962-9201; Web site: www.bio.org.

© 2008 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024